Lykos Therapeutics (formerly MAPS PBC)
Sarah Murray currently serves as a Senior Quality Associate at Lykos Therapeutics, a position held since July 2023. Prior to this role, Sarah worked as a Senior Clinical Research Compliance Specialist and Clinical Research Compliance Specialist at the University of Pennsylvania from April 2021 to June 2023. Previous experience includes serving as a Clinical Trial Specialist at PRA Health Sciences and a Quality Assurance Auditor at QPS Holdings, LLC. Sarah also contributed to research as a Research Assistant at Neumann University, where tasks included assisting in the synthesis of antimicrobial peptides and teaching as a Student Instructor. Sarah holds a degree from Neumann University, where studies were completed from 2015 to 2018, and attended Chichester High School from 2010 to 2014.
This person is not in the org chart
Lykos Therapeutics (formerly MAPS PBC)
At Lykos Therapeutics, our mission is to transform the way mental health is treated. We aspire to challenge the status quo through the development of novel therapies and therapeutic approaches to treat mental health conditions. With 30+ years of experience researching psychedelic-assisted therapies, we remain focused on following rigorous science from which we can develop and commercialize novel treatment options. Founded in 2014 by the non-profit Multidisciplinary Association for Psychedelic Studies (“MAPS”), we are a for-profit public benefit corporation (“PBC”). As a PBC, we consider the impact of our decisions on society just as we think about financial implications. Everything we do is looked at through a public benefit lens. To learn more, visit us at www.lykospbc.com.